APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio-coupling Drug Outsourcing Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bio-coupling Drug Outsourcing Services Market Outlook and Growth Opportunities 2026

2 May 2026192 pages

Choose your research edition.

Industry ResearchBio-coupling Drug Outsourcing Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio-coupling Drug Outsourcing Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Bio-coupling Drug Outsourcing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio-coupling Drug Outsourcing Services Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio-coupling Drug Outsourcing Services Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Bio-coupling Drug Outsourcing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bio-coupling Drug Outsourcing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bio-coupling Drug Outsourcing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bio-coupling Drug Outsourcing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bio-coupling Drug Outsourcing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bio-coupling Drug Outsourcing Services market include Lonza, BSP Pharmaceuticals, Catalent, Merck, WuXi XDC Cayman Inc, Thermo Fisher Scientific, Samsung Biologics, Recipharm and Axplora, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bio-coupling Drug Outsourcing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bio-coupling Drug Outsourcing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bio-coupling Drug Outsourcing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bio-coupling Drug Outsourcing Services market.

Bio-coupling Drug Outsourcing Services Segment by Company

Lonza

BSP Pharmaceuticals

Catalent

Merck

WuXi XDC Cayman Inc

Thermo Fisher Scientific

Samsung Biologics

Recipharm

Axplora

Sterling Pharmaceuticals、

NJ Bio, Inc

Piramal Grangemouth

Abzena

Fleet Bioprocessing

MabPlex international

Toyo Pharm

Aobak

Asymchem

Porton Pharma Solutions

Bio-coupling Drug Outsourcing Services Segment by Type

Antibody Drug Coupling Outsourcing Services

Dual Anticoupling Material Outsourcing Services

Antibody Oligonucleotide Coupling Outsourcing Services

Others

Bio-coupling Drug Outsourcing Services Segment by Application

Tumor Treatment

Autoimmune Disease Treatment

Treatment of Metabolic Disorders

Others

Bio-coupling Drug Outsourcing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bio-coupling Drug Outsourcing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bio-coupling Drug Outsourcing Services key companies, revenue, market share, and recent developments.

3. To split the Bio-coupling Drug Outsourcing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bio-coupling Drug Outsourcing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bio-coupling Drug Outsourcing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Bio-coupling Drug Outsourcing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-coupling Drug Outsourcing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio-coupling Drug Outsourcing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-coupling Drug Outsourcing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bio-coupling Drug Outsourcing Services industry.

Chapter 3: Detailed analysis of Bio-coupling Drug Outsourcing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bio-coupling Drug Outsourcing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bio-coupling Drug Outsourcing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bio-coupling Drug Outsourcing Services Industry Trends Table 2. Bio-coupling Drug Outsourcing Services Industry Drivers Table 3. Bio-coupling Drug Outsourcing Services Industry Opportunities and Challenges Table 4. Bio-coupling Drug Outsourcing Services Industry Restraints Table 5. Global Bio-coupling Drug Outsourcing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bio-coupling Drug Outsourcing Services Revenue Share by Company (2021-2026) Table 7. Global Bio-coupling Drug Outsourcing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bio-coupling Drug Outsourcing Services Key Company Manufacturing Base & Headquarters Table 9. Global Bio-coupling Drug Outsourcing Services Company, Product Type & Application Table 10. Global Bio-coupling Drug Outsourcing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bio-coupling Drug Outsourcing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Antibody Drug Coupling Outsourcing Services Table 15. Significant Companies of Dual Anticoupling Material Outsourcing Services Table 16. Significant Companies of Antibody Oligonucleotide Coupling Outsourcing Services Table 17. Significant Companies of Others Table 18. Global Bio-coupling Drug Outsourcing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Bio-coupling Drug Outsourcing Services Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Bio-coupling Drug Outsourcing Services Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Bio-coupling Drug Outsourcing Services Sales Value Share by Type (2021-2026) Table 22. Global Bio-coupling Drug Outsourcing Services Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Tumor Treatment Table 24. Significant Companies of Autoimmune Disease Treatment Table 25. Significant Companies of Treatment of Metabolic Disorders Table 26. Significant Companies of Others Table 27. Global Bio-coupling Drug Outsourcing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Bio-coupling Drug Outsourcing Services Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Bio-coupling Drug Outsourcing Services Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Bio-coupling Drug Outsourcing Services Sales Value Share by Application (2021-2026) Table 31. Global Bio-coupling Drug Outsourcing Services Sales Value Share by Application (2027-2032) Table 32. Global Bio-coupling Drug Outsourcing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Bio-coupling Drug Outsourcing Services Sales Value Share by Region (2021-2026) Table 35. Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Bio-coupling Drug Outsourcing Services Sales Value Share by Region (2027-2032) Table 37. Global Bio-coupling Drug Outsourcing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Bio-coupling Drug Outsourcing Services Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Bio-coupling Drug Outsourcing Services Sales Value Market Share by Country (2021-2026) Table 40. Global Bio-coupling Drug Outsourcing Services Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Bio-coupling Drug Outsourcing Services Sales Value Market Share by Country (2027-2032) Table 42. Lonza Company Information Table 43. Lonza Business Overview Table 44. Lonza Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Lonza Bio-coupling Drug Outsourcing Services Product Portfolio Table 46. Lonza Recent Development Table 47. BSP Pharmaceuticals Company Information Table 48. BSP Pharmaceuticals Business Overview Table 49. BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Product Portfolio Table 51. BSP Pharmaceuticals Recent Development Table 52. Catalent Company Information Table 53. Catalent Business Overview Table 54. Catalent Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Catalent Bio-coupling Drug Outsourcing Services Product Portfolio Table 56. Catalent Recent Development Table 57. Merck Company Information Table 58. Merck Business Overview Table 59. Merck Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Merck Bio-coupling Drug Outsourcing Services Product Portfolio Table 61. Merck Recent Development Table 62. WuXi XDC Cayman Inc Company Information Table 63. WuXi XDC Cayman Inc Business Overview Table 64. WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Product Portfolio Table 66. WuXi XDC Cayman Inc Recent Development Table 67. Thermo Fisher Scientific Company Information Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Product Portfolio Table 71. Thermo Fisher Scientific Recent Development Table 72. Samsung Biologics Company Information Table 73. Samsung Biologics Business Overview Table 74. Samsung Biologics Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Samsung Biologics Bio-coupling Drug Outsourcing Services Product Portfolio Table 76. Samsung Biologics Recent Development Table 77. Recipharm Company Information Table 78. Recipharm Business Overview Table 79. Recipharm Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Recipharm Bio-coupling Drug Outsourcing Services Product Portfolio Table 81. Recipharm Recent Development Table 82. Axplora Company Information Table 83. Axplora Business Overview Table 84. Axplora Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Axplora Bio-coupling Drug Outsourcing Services Product Portfolio Table 86. Axplora Recent Development Table 87. Sterling Pharmaceuticals、 Company Information Table 88. Sterling Pharmaceuticals、 Business Overview Table 89. Sterling Pharmaceuticals、 Bio-coupling Drug Outsourcing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sterling Pharmaceuticals、 Bio-coupling Drug Outsourcing Services Product Portfolio Table 91. Sterling Pharmaceuticals、 Recent Development Table 92. NJ Bio, Inc Company Information Table 93. NJ Bio, Inc Business Overview Table 94. NJ Bio, Inc Bio-coupling Drug Outsourcing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. NJ Bio, Inc Bio-coupling Drug Outsourcing Services Product Portfolio Table 96. NJ Bio, Inc Recent Development Table 97. Piramal Grangemouth Company Information Table 98. Piramal Grangemouth Business Overview Table 99. Piramal Grangemouth Bio-coupling Drug Outsourcing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Piramal Grangemouth Bio-coupling Drug Outsourcing Services Product Portfolio Table 101. Piramal Grangemouth Recent Development Table 102. Abzena Company Information Table 103. Abzena Business Overview Table 104. Abzena Bio-coupling Drug Outsourcing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Abzena Bio-coupling Drug Outsourcing Services Product Portfolio Table 106. Abzena Recent Development Table 107. Fleet Bioprocessing Company Information Table 108. Fleet Bioprocessing Business Overview Table 109. Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Product Portfolio Table 111. Fleet Bioprocessing Recent Development Table 112. MabPlex international Company Information Table 113. MabPlex international Business Overview Table 114. MabPlex international Bio-coupling Drug Outsourcing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. MabPlex international Bio-coupling Drug Outsourcing Services Product Portfolio Table 116. MabPlex international Recent Development Table 117. Toyo Pharm Company Information Table 118. Toyo Pharm Business Overview Table 119. Toyo Pharm Bio-coupling Drug Outsourcing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Toyo Pharm Bio-coupling Drug Outsourcing Services Product Portfolio Table 121. Toyo Pharm Recent Development Table 122. Aobak Company Information Table 123. Aobak Business Overview Table 124. Aobak Bio-coupling Drug Outsourcing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Aobak Bio-coupling Drug Outsourcing Services Product Portfolio Table 126. Aobak Recent Development Table 127. Asymchem Company Information Table 128. Asymchem Business Overview Table 129. Asymchem Bio-coupling Drug Outsourcing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Asymchem Bio-coupling Drug Outsourcing Services Product Portfolio Table 131. Asymchem Recent Development Table 132. Porton Pharma Solutions Company Information Table 133. Porton Pharma Solutions Business Overview Table 134. Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Product Portfolio Table 136. Porton Pharma Solutions Recent Development Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Bio-coupling Drug Outsourcing Services Product Image Figure 2. Global Bio-coupling Drug Outsourcing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio-coupling Drug Outsourcing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Bio-coupling Drug Outsourcing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Antibody Drug Coupling Outsourcing Services Image Figure 8. Dual Anticoupling Material Outsourcing Services Image Figure 9. Antibody Oligonucleotide Coupling Outsourcing Services Image Figure 10. Others Image Figure 11. Global Bio-coupling Drug Outsourcing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Bio-coupling Drug Outsourcing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Bio-coupling Drug Outsourcing Services Sales Value Share by Type (2021-2032) Figure 14. Tumor Treatment Image Figure 15. Autoimmune Disease Treatment Image Figure 16. Treatment of Metabolic Disorders Image Figure 17. Others Image Figure 18. Global Bio-coupling Drug Outsourcing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Bio-coupling Drug Outsourcing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Bio-coupling Drug Outsourcing Services Sales Value Share by Application (2021-2032) Figure 21. Global Bio-coupling Drug Outsourcing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Bio-coupling Drug Outsourcing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Bio-coupling Drug Outsourcing Services Sales Value (2021-2032) & (US$ Million) Figure 24. North America Bio-coupling Drug Outsourcing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Bio-coupling Drug Outsourcing Services Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Bio-coupling Drug Outsourcing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Bio-coupling Drug Outsourcing Services Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Bio-coupling Drug Outsourcing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Bio-coupling Drug Outsourcing Services Sales Value (2021-2032) & (US$ Million) Figure 30. South America Bio-coupling Drug Outsourcing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Bio-coupling Drug Outsourcing Services Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Bio-coupling Drug Outsourcing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Antibody Drug Coupling Outsourcing Services
  • Dual Anticoupling Material Outsourcing Services
  • Antibody Oligonucleotide Coupling Outsourcing Services
  • Others
Applications
  • Tumor Treatment
  • Autoimmune Disease Treatment
  • Treatment of Metabolic Disorders
  • Others
Companies covered
  • Lonza
  • BSP Pharmaceuticals
  • Catalent
  • Merck
  • WuXi XDC Cayman Inc
  • Thermo Fisher Scientific
  • Samsung Biologics
  • Recipharm
  • Axplora
  • Sterling Pharmaceuticals、
  • NJ Bio, Inc
  • Piramal Grangemouth
  • Abzena
  • Fleet Bioprocessing
  • MabPlex international
  • Toyo Pharm
  • Aobak
  • Asymchem
  • Porton Pharma Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bio-coupling Drug Outsourcing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bio-coupling Drug Outsourcing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bio-coupling Drug Outsourcing Services Market Dynamics
  1. 2.1 Bio-coupling Drug Outsourcing Services Industry Trends
  2. 2.2 Bio-coupling Drug Outsourcing Services Industry Drivers
  3. 2.3 Bio-coupling Drug Outsourcing Services Industry Opportunities and Challenges
  4. 2.4 Bio-coupling Drug Outsourcing Services Industry Restraints
3 Bio-coupling Drug Outsourcing Services Market by Company
  1. 3.1 Global Bio-coupling Drug Outsourcing Services Company Revenue Ranking in 2025
  2. 3.2 Global Bio-coupling Drug Outsourcing Services Revenue by Company (2021-2026)
  3. 3.3 Global Bio-coupling Drug Outsourcing Services Company Ranking (2024-2026)
  4. 3.4 Global Bio-coupling Drug Outsourcing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Bio-coupling Drug Outsourcing Services Company Product Type and Application
  6. 3.6 Global Bio-coupling Drug Outsourcing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bio-coupling Drug Outsourcing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bio-coupling Drug Outsourcing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bio-coupling Drug Outsourcing Services Market by Type
  1. 4.1 Bio-coupling Drug Outsourcing Services Type Introduction
  2. 4.1.1 Antibody Drug Coupling Outsourcing Services
  3. 4.1.2 Dual Anticoupling Material Outsourcing Services
  4. 4.1.3 Antibody Oligonucleotide Coupling Outsourcing Services
  5. 4.1.4 Others
  6. 4.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Type
  7. 4.2.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Type (2021-2032)
  9. 4.2.3 Global Bio-coupling Drug Outsourcing Services Sales Value Share by Type (2021-2032)
5 Bio-coupling Drug Outsourcing Services Market by Application
  1. 5.1 Bio-coupling Drug Outsourcing Services Application Introduction
  2. 5.1.1 Tumor Treatment
  3. 5.1.2 Autoimmune Disease Treatment
  4. 5.1.3 Treatment of Metabolic Disorders
  5. 5.1.4 Others
  6. 5.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Application
  7. 5.2.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Bio-coupling Drug Outsourcing Services Sales Value Share by Application (2021-2032)
6 Bio-coupling Drug Outsourcing Services Regional Value Analysis
  1. 6.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bio-coupling Drug Outsourcing Services Sales Value (2021-2032)
  7. 6.3.2 North America Bio-coupling Drug Outsourcing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bio-coupling Drug Outsourcing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Bio-coupling Drug Outsourcing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bio-coupling Drug Outsourcing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bio-coupling Drug Outsourcing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bio-coupling Drug Outsourcing Services Sales Value (2021-2032)
  16. 6.6.2 South America Bio-coupling Drug Outsourcing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bio-coupling Drug Outsourcing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bio-coupling Drug Outsourcing Services Sales Value Share by Country, 2025 VS 2032
7 Bio-coupling Drug Outsourcing Services Country-level Value Analysis
  1. 7.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bio-coupling Drug Outsourcing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bio-coupling Drug Outsourcing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bio-coupling Drug Outsourcing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza
  2. 8.1.1 Lonza Company Information
  3. 8.1.2 Lonza Business Overview
  4. 8.1.3 Lonza Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Bio-coupling Drug Outsourcing Services Product Portfolio
  6. 8.1.5 Lonza Recent Developments
  7. 8.2 BSP Pharmaceuticals
  8. 8.2.1 BSP Pharmaceuticals Company Information
  9. 8.2.2 BSP Pharmaceuticals Business Overview
  10. 8.2.3 BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Product Portfolio
  12. 8.2.5 BSP Pharmaceuticals Recent Developments
  13. 8.3 Catalent
  14. 8.3.1 Catalent Company Information
  15. 8.3.2 Catalent Business Overview
  16. 8.3.3 Catalent Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Catalent Bio-coupling Drug Outsourcing Services Product Portfolio
  18. 8.3.5 Catalent Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Bio-coupling Drug Outsourcing Services Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 WuXi XDC Cayman Inc
  26. 8.5.1 WuXi XDC Cayman Inc Company Information
  27. 8.5.2 WuXi XDC Cayman Inc Business Overview
  28. 8.5.3 WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Product Portfolio
  30. 8.5.5 WuXi XDC Cayman Inc Recent Developments
  31. 8.6 Thermo Fisher Scientific
  32. 8.6.1 Thermo Fisher Scientific Company Information
  33. 8.6.2 Thermo Fisher Scientific Business Overview
  34. 8.6.3 Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Product Portfolio
  36. 8.6.5 Thermo Fisher Scientific Recent Developments
  37. 8.7 Samsung Biologics
  38. 8.7.1 Samsung Biologics Company Information
  39. 8.7.2 Samsung Biologics Business Overview
  40. 8.7.3 Samsung Biologics Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Samsung Biologics Bio-coupling Drug Outsourcing Services Product Portfolio
  42. 8.7.5 Samsung Biologics Recent Developments
  43. 8.8 Recipharm
  44. 8.8.1 Recipharm Company Information
  45. 8.8.2 Recipharm Business Overview
  46. 8.8.3 Recipharm Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Recipharm Bio-coupling Drug Outsourcing Services Product Portfolio
  48. 8.8.5 Recipharm Recent Developments
  49. 8.9 Axplora
  50. 8.9.1 Axplora Company Information
  51. 8.9.2 Axplora Business Overview
  52. 8.9.3 Axplora Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Axplora Bio-coupling Drug Outsourcing Services Product Portfolio
  54. 8.9.5 Axplora Recent Developments
  55. 8.10 Sterling Pharmaceuticals、
  56. 8.10.1 Sterling Pharmaceuticals、 Company Information
  57. 8.10.2 Sterling Pharmaceuticals、 Business Overview
  58. 8.10.3 Sterling Pharmaceuticals、 Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sterling Pharmaceuticals、 Bio-coupling Drug Outsourcing Services Product Portfolio
  60. 8.10.5 Sterling Pharmaceuticals、 Recent Developments
  61. 8.11 NJ Bio, Inc
  62. 8.11.1 NJ Bio, Inc Company Information
  63. 8.11.2 NJ Bio, Inc Business Overview
  64. 8.11.3 NJ Bio, Inc Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NJ Bio, Inc Bio-coupling Drug Outsourcing Services Product Portfolio
  66. 8.11.5 NJ Bio, Inc Recent Developments
  67. 8.12 Piramal Grangemouth
  68. 8.12.1 Piramal Grangemouth Company Information
  69. 8.12.2 Piramal Grangemouth Business Overview
  70. 8.12.3 Piramal Grangemouth Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Piramal Grangemouth Bio-coupling Drug Outsourcing Services Product Portfolio
  72. 8.12.5 Piramal Grangemouth Recent Developments
  73. 8.13 Abzena
  74. 8.13.1 Abzena Company Information
  75. 8.13.2 Abzena Business Overview
  76. 8.13.3 Abzena Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Abzena Bio-coupling Drug Outsourcing Services Product Portfolio
  78. 8.13.5 Abzena Recent Developments
  79. 8.14 Fleet Bioprocessing
  80. 8.14.1 Fleet Bioprocessing Company Information
  81. 8.14.2 Fleet Bioprocessing Business Overview
  82. 8.14.3 Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Product Portfolio
  84. 8.14.5 Fleet Bioprocessing Recent Developments
  85. 8.15 MabPlex international
  86. 8.15.1 MabPlex international Company Information
  87. 8.15.2 MabPlex international Business Overview
  88. 8.15.3 MabPlex international Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 MabPlex international Bio-coupling Drug Outsourcing Services Product Portfolio
  90. 8.15.5 MabPlex international Recent Developments
  91. 8.16 Toyo Pharm
  92. 8.16.1 Toyo Pharm Company Information
  93. 8.16.2 Toyo Pharm Business Overview
  94. 8.16.3 Toyo Pharm Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Toyo Pharm Bio-coupling Drug Outsourcing Services Product Portfolio
  96. 8.16.5 Toyo Pharm Recent Developments
  97. 8.17 Aobak
  98. 8.17.1 Aobak Company Information
  99. 8.17.2 Aobak Business Overview
  100. 8.17.3 Aobak Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Aobak Bio-coupling Drug Outsourcing Services Product Portfolio
  102. 8.17.5 Aobak Recent Developments
  103. 8.18 Asymchem
  104. 8.18.1 Asymchem Company Information
  105. 8.18.2 Asymchem Business Overview
  106. 8.18.3 Asymchem Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Asymchem Bio-coupling Drug Outsourcing Services Product Portfolio
  108. 8.18.5 Asymchem Recent Developments
  109. 8.19 Porton Pharma Solutions
  110. 8.19.1 Porton Pharma Solutions Company Information
  111. 8.19.2 Porton Pharma Solutions Business Overview
  112. 8.19.3 Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Product Portfolio
  114. 8.19.5 Porton Pharma Solutions Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst